why choose us

First received: July 25, 2024

Clinical Trial: Unique Treatment of Oncology Pain in Advanced Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cancer Pain

Study Type: INTERVENTIONAL


Official Title: A Phase 2A Study to Investigate the Safety and Preliminary Analgesic Efficacy of Oral Trichomylin® in Male and Female Participants 18 Years of Age and Above With Advanced Cancer and Moderate to Severe

Brief Summary: This will be a proof-of-concept, single arm study with a maximum of 20 patients to evaluate preliminary analgesic efficacy and safety of Trichomylin® in patients with advanced cancer (male and female) who suffer from moderate to severe chronic pain and who are taking a stable dose of long-acting opioid therapy for at least 1 week prior to screening.

Read more